![Ameet Mallik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ameet Mallik
Directeur Général chez
ADC THERAPEUTICS SA
Fortune : 2 M $ au 30/06/2026
Profil
Ameet Mallik currently works at ADC Therapeutics SA, as President, Chief Executive Officer & Director from 2022.
Mr. Mallik also formerly worked at Cornerstone Pharmaceuticals, Inc., as Non-Executive Chairman, Rafael Holdings, Inc., as Director in 2022, Atara Biotherapeutics, Inc., as Independent Director from 2021 to 2025, Novartis Oncology, Inc., as Global Head-Marketing, Value & Access from 2015 to 2017, Novartis AG, as Executive Vice President & Head-US Oncology from 2017 to 2021, McKinsey & Co., Inc., as Associate Principal, and Sandoz International GmbH, as Head-Biopharmaceuticals & Oncology Injectables from 2009 to 2014.
Mr. Mallik received his undergraduate degree and graduate degree from Northwestern University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 1,67 % | 30/06/2026 | 2 121 769 ( 1,67 % ) | 2 M $ | 30/06/2026 |
| 10/06/2025 | 16 928 ( 0,19 % ) | 194 333 $ | 30/06/2026 |
Postes actifs de Ameet Mallik
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur Général | 09/05/2022 |
Anciens postes connus de Ameet Mallik
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/09/2025 |
| RAFAEL HOLDINGS, INC. | Directeur Général | 01/02/2022 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/11/2015 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Corporate Officer/Principal | 01/04/2014 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Formation de Ameet Mallik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
